Title: RF-amide related peptide-3 (RFRP-3): a novel neuroendocrine regulator of energy homeostasis, metabolism, and reproduction
| dc.contributor.author | Shabana Anjum | |
| dc.contributor.author | Muhammad Nasir Khan Khattak | |
| dc.contributor.author | Kazuyoshi Tsutsui | |
| dc.contributor.author | Amitabh Krishna | |
| dc.date.accessioned | 2026-02-07T10:43:06Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | A hypothalamic neuropeptide, RF-amide related peptide-3 (RFRP-3), the mammalian ortholog of the avian gonadotropin-inhibitory hormone (GnIH) has inhibitory signals for reproductive axis via G-protein coupled receptor 147 in mammals. Moreover, RFRP-3 has orexigenic action but the mechanism involved in energy homeostasis and glucose metabolism is not yet known. Though, the RFRP-3 modulates orexigenic action in co-operation with other neuropeptides, which regulates metabolic cues in the hypothalamus. Administration of GnIH/RFRP-3 suppresses plasma luteinizing hormone, at the same time stimulates feeding behavior in birds and mammals. Likewise, in the metabolically deficient conditions, its expression is up-regulated suggests that RFRP-3 contributes to the integration of energy balance and reproduction. However, in many other metabolic conditions like induced diabetes and high-fat diet obesity, etc. its role is still not clear while, RFRP-3 induces the glucose homeostasis by adipocytes is reported. The physiological role of RFRP-3 in metabolic homeostasis and the metabolic effects of RFRP-3 signaling in pharmacological studies need a detailed discussion. Further studies are required to find out whether RFRP-3 is associated with restricted neuroendocrine function observed in type II diabetes mellitus, aging, or sub-fertility. In this context, the current review is focused on the role of RFRP-3 in the above-mentioned mechanisms. Studies from search engines including PubMed, Google Scholar, and science.gov are included after following set inclusion/exclusion criteria. As a developing field few mechanisms are still inconclusive, however, based on the available information RFRP-3 seems to be a putative tool in future treatment strategies towards metabolic disease. © 2021, The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature. | |
| dc.identifier.doi | 10.1007/s11033-021-06198-z | |
| dc.identifier.issn | 3014851 | |
| dc.identifier.uri | https://doi.org/10.1007/s11033-021-06198-z | |
| dc.identifier.uri | https://dl.bhu.ac.in/bhuir/handle/123456789/38203 | |
| dc.publisher | Springer Science and Business Media B.V. | |
| dc.subject | Energy homeostasis | |
| dc.subject | GPR147 | |
| dc.subject | Metabolic deficient condition | |
| dc.subject | RFRP-3/GnIH | |
| dc.title | RF-amide related peptide-3 (RFRP-3): a novel neuroendocrine regulator of energy homeostasis, metabolism, and reproduction | |
| dc.type | Publication | |
| dspace.entity.type | Review |
